WHO interpretation of guidelines for COVID-19 considerations for tuberculosis (TB) care

doi:10.19871/j.cnki.xfcrbzz.2021.03.022

Abstract

Abstract: For guiding all countries to prevent, control,and reduce the spread of tuberculosis in the COVID-19 pandemic, the World Health Organization experts drew up and issued the COVID-19 considerations for tuberculosis (TB) care. We briefly review the established background, main content, and characteristics of the guideline so that practitioners in the field can better understand the relevant knowledge and improve the ability of prevention and control.

Key words: Tuberculosis, Prevention and control, Coronavirus disease 2019, Comments

Chen Qiuqi, Deng Guofang. WHO interpretation of guidelines for COVID-19 considerations for tuberculosis (TB) care[J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(3): 265-269.

References

[1] World Health Organization.WHO Information Note: COVID-19 considerations for tuberculosis (TB) care[EB/OL]. [2021-05-05].https://www.who.int/publications/i/item/WHO-2019-nCoV-TB-care-2021.1.
[2] GLAZIOU P. Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in2020 [OL].[2021-05-04]. https://www.researchgate.net/publication/341137859_Predicted_impact_of_the_COVID-19_pandemic_on_global_tuberculosis_deaths_in_2020.
[3] ALAGNA R, BESOZZI G, CODECASA LR, et al.Celebrating World Tuberculosis Day at the time of COVID-19[J]. Eur Respir J,2020,55(4):2000650.
[4] GRABER-STIEHL I.The silent epidemic killing more people than HIV, malaria or TB[J].Nature, 2018, 564(7734): 24-26.
[5] 任坦坦,陆普选,邓国防,等. 2020 WHO全球结核报告:全球与中国关键数据分析[J/CD]. 新发传染病电子杂志,2020,5(4):280-284.
[6] GLYNN JR, GUERRA-ASSUNÇÃO JA, HOUBEN RMGJ, et al. Whole Genome Sequencing Shows a Low Proportion of Tuberculosis Disease Is Attributable to Known Close Contacts in Rural Malawi[J]. PloS One, 2015,10(7):e0132840-e0132840.
[7] MCQUAID CF, MCCREESH N, READ JM, et al.The potential impact of COVID-19-related disruption on tuberculosis burden[J]. Eur Respir J, 202, 56(2):2001718.
[8] STOP TB PARTNERSHIP. The potential impact of the covid-19 response on tuberculosis in high-burden countries: a modelling analysis[OL].Stop TB Partnership, 2020. Available from:http://www.stoptb.org/assets/documents/news/Modeling%20Report_1%20May%202020_FINAL.pdf
[9] WORLD HEALTH ORGANIZATION.Impact of the COVID-19 pandemic on TB detection and mortality in 2020[EB/OL].[2021-03-22].https://www.who.int/publications/m/item/impact-of-the-covid-19-pandemic-on-tb-detection-and-mortality-in-2020.
[10] ROBERTS L.How COVID hurt the fight against other dangerous diseases[J]. Nature, 2021,592(7855):502-504.
[11] VISCA D, TIBERI S, PONTALI E, et al.Tuberculosis in the time of COVID-19: quality of life and digital innovation[J]. Eur Respir J, 2020, 56(2):2001998.
[12] WORLD HEALTH ORGANIZATION.Coronavirus disease (COVID-19): How is it transmitted?[EB/OL]. [2020-11-30].https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted.
[13] WORLD HEALTH ORGANIZATION.Mask use in the context of COVID-19[EB/OL]. [2020-12-01].https://apps.who.int/iris/bitstream/handle/10665/337199/WHO-2019-nCov-IPC_Masks-2020.5-eng.pdf?sequence=1&isAllowed=y.
[14] WORLD HEALTH ORGANIZATION.WHO consolidated guidelines on tuberculosis. Module 4: Treatment - drug-resistant tuberculosis treatment [EB/OL].[2020-06-15]. https://www.who.int/publications/i/item/9789240007048.
[15] DAVIES MA. HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa. medRxiv [J/OL].2020 Jul 3:2020.07.02.20145185.
[16] TADOLINI M, CODECASA LR, GARCÍA-GARCÍA JM, et al. Active tuberculosis, sequelae andCOVID-19 co-infection: first cohort of 49 cases[J]. Eur Respir J, 2020, 56(1):2001398
[17] MOTTA I, CENTIS R, D'AMBROSIO L, et al. Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts[J]. Pulmonology, 2020, 26(4):233-240.
[18] GUPTA N, ISH P, GUPTA A, et al.A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis[J]. Eur Respir J, 2020, 56(5):2003408.
[19] STOCHINO C, VILLA S, ZUCCHI P,et al.Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital[J]. Eur Respir J, 2020,56(1):2001708.
[20] WORLD HEALTH ORGANIZATION.Infection prevention and control during health care when coronavirus disease2019 is suspected or confirmed[EB/OL].[2020-04-06]. https://apps.who.int/iris/rest/bitstreams/1284718/retrieve
[21] SAUNDERS MJ, WINGFIELD T, TOVAR MA, et al.A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: A prospective derivation and external validation cohort study[J]. Lancet Infect Dis, 17(11):1190-1199.
[22] SAUNDERS MJ, WINGFIELD T, DATTA S, et al.A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study[J]. Lancet Infect Dis, 2020, 20(1):110-122.
[23] WORLD HEALTH ORGANIZATION.WHO consolidated guidelines on tuberculosis. Module 2: Screening - systematic screening for tuberculosis disease[EB/OL].[2020-03-22]. https://apps.who.int/iris/handle/10665/340255.
[24] WORLD HEALTH ORGANIZATION.WHO operational handbook on tuberculosis. Module 2: Screening - systematic screening for tuberculosis disease[EB/OL].[2021-03-22]. https://apps.who.int/iris/handle/10665/340256.
[25] ABDOOL KQ, ABDOOL KSS.COVID-19 affects HIV and tuberculosis care[J]. Science, 2020, 369(6502):366-368.
[26] WINGFIELD T, KARMADWALA F, MACPHERSON P, et al.Challenges and opportunities to end tuberculosis in the COVID-19 era[J].Lancet Respir Med, 2021,9(6):556-558.
[27] 李倩,卢洪洲. 新型冠状病毒疫苗研究最新进展[J/CD]. 新发传染病电子杂志,2020,5(4):268-273.